Literature DB >> 23922129

Cell cycle arrest in a model of colistin nephrotoxicity.

Michael T Eadon1, Bradley K Hack, Jessy J Alexander, Chang Xu, M Eileen Dolan, Patrick N Cunningham.   

Abstract

Colistin (polymixin E) is an antibiotic prescribed with resurging frequency for multidrug resistant gram negative bacterial infections. It is associated with nephrotoxicity in humans in up to 55% of cases. Little is known regarding genes involved in colistin nephrotoxicity. A murine model of colistin-mediated kidney injury was developed. C57/BL6 mice were administered saline or colistin at a dose of 16 mg/kg/day in 2 divided intraperitoneal doses and killed after either 3 or 15 days of colistin. After 15 days, mice exposed to colistin had elevated blood urea nitrogen (BUN), creatinine, and pathologic evidence of acute tubular necrosis and apoptosis. After 3 days, mice had neither BUN elevation nor substantial pathologic injury; however, urinary neutrophil gelatinase-associated lipocalin was elevated (P = 0.017). An Illumina gene expression array was performed on kidney RNA harvested 72 h after first colistin dose to identify differentially expressed genes early in drug treatment. Array data revealed 21 differentially expressed genes (false discovery rate < 0.1) between control and colistin-exposed mice, including LGALS3 and CCNB1. The gene signature was significantly enriched for genes involved in cell cycle proliferation. RT-PCR, immunoblot, and immunostaining validated the relevance of key genes and proteins. This murine model offers insights into the potential mechanism of colistin-mediated nephrotoxicity. Further studies will determine whether the identified genes play a causative or protective role in colistin-induced nephrotoxicity.

Entities:  

Keywords:  cell cycle; colistin; galectin-3; nephrotoxicity; polymyxin E; renal failure

Mesh:

Substances:

Year:  2013        PMID: 23922129      PMCID: PMC3798781          DOI: 10.1152/physiolgenomics.00076.2013

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  69 in total

Review 1.  Use of transcriptomics in understanding mechanisms of drug-induced toxicity.

Authors:  Yuxia Cui; Richard S Paules
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

Review 2.  Transcription-independent p53 apoptosis: an alternative route to death.

Authors:  Daniel Speidel
Journal:  Trends Cell Biol       Date:  2009-10-30       Impact factor: 20.808

3.  Effectiveness and safety of colistin: prospective comparative cohort study.

Authors:  Mical Paul; Jihad Bishara; Ariela Levcovich; Michal Chowers; Elad Goldberg; Pierre Singer; Shaul Lev; Perla Leon; Maria Raskin; Dafna Yahav; Leonard Leibovici
Journal:  J Antimicrob Chemother       Date:  2010-03-18       Impact factor: 5.790

4.  Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury.

Authors:  Li Yang; Tatiana Y Besschetnova; Craig R Brooks; Jagesh V Shah; Joseph V Bonventre
Journal:  Nat Med       Date:  2010-05-02       Impact factor: 53.440

5.  Up-regulation of galectin-3 in acute renal failure of the rat.

Authors:  J Nishiyama; S Kobayashi; A Ishida; I Nakabayashi; O Tajima; S Miura; M Katayama; H Nogami
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

6.  Galectin-3 mediates genistein-induced G(2)/M arrest and inhibits apoptosis.

Authors:  H M Lin; B K Moon; F Yu; H R Kim
Journal:  Carcinogenesis       Date:  2000-11       Impact factor: 4.944

7.  Predictors of acute kidney injury associated with intravenous colistin treatment.

Authors:  Jeong-Ah Kwon; Jung Eun Lee; Wooseong Huh; Kyong Ran Peck; Yoon-Goo Kim; Dae Joong Kim; Ha Young Oh
Journal:  Int J Antimicrob Agents       Date:  2010-01-20       Impact factor: 5.283

Review 8.  The cell cycle and acute kidney injury.

Authors:  Peter M Price; Robert L Safirstein; Judit Megyesi
Journal:  Kidney Int       Date:  2009-06-17       Impact factor: 10.612

9.  Nephrotoxicity associated with the use of intravenous colistin.

Authors:  Cecilia Santamaría; Analia Mykietiuk; Elena Temporiti; Martin E Stryjewski; Fabian Herrera; Pablo Bonvehi
Journal:  Scand J Infect Dis       Date:  2009

10.  Clinical characteristics and risk factors of colistin-induced nephrotoxicity.

Authors:  Jieun Kim; Kyoung-Ho Lee; Sunmi Yoo; Hyunjoo Pai
Journal:  Int J Antimicrob Agents       Date:  2009-09-01       Impact factor: 5.283

View more
  15 in total

1.  Major pathways of polymyxin-induced apoptosis in rat kidney proximal tubular cells.

Authors:  Mohammad A K Azad; Jesmin Akter; Kelly L Rogers; Roger L Nation; Tony Velkov; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

Review 2.  Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?

Authors:  Thien B Tran; Tony Velkov; Roger L Nation; Alan Forrest; Brian T Tsuji; Phillip J Bergen; Jian Li
Journal:  Int J Antimicrob Agents       Date:  2016-10-18       Impact factor: 5.283

3.  Colistin-induced nephrotoxicity in mice involves the mitochondrial, death receptor, and endoplasmic reticulum pathways.

Authors:  Chongshan Dai; Jichang Li; Shusheng Tang; Jian Li; Xilong Xiao
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 4.  Nephrotoxicity of Polymyxins: Is There Any Difference between Colistimethate and Polymyxin B?

Authors:  Alexandre P Zavascki; Roger L Nation
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 5.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

6.  Baicalein acts as a nephroprotectant that ameliorates colistin-induced nephrotoxicity by activating the antioxidant defence mechanism of the kidneys and down-regulating the inflammatory response.

Authors:  Chongshan Dai; Shusheng Tang; Yang Wang; Tony Velkov; Xilong Xiao
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

7.  A two-week regimen of high-dose integrase inhibitors does not cause nephrotoxicity in mice.

Authors:  Michael T Eadon; Hongji Zhang; Todd C Skaar; Takashi Hato; Pierre C Dagher; Samir K Gupta; Zeruesenay Desta
Journal:  Antivir Chem Chemother       Date:  2015-07-30

8.  Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells.

Authors:  Johnny X Huang; Geraldine Kaeslin; Max V Ranall; Mark A Blaskovich; Bernd Becker; Mark S Butler; Melissa H Little; Lawrence H Lash; Matthew A Cooper
Journal:  Pharmacol Res Perspect       Date:  2015-05-15

Review 9.  Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives.

Authors:  Yinggang Zhu; Antoine Monsel; Jason A Roberts; Konstantinos Pontikis; Olivier Mimoz; Jordi Rello; Jieming Qu; Jean-Jacques Rouby
Journal:  Microorganisms       Date:  2021-05-27

10.  P-Glycoprotein Induction Ameliorates Colistin Induced Nephrotoxicity in Cultured Human Proximal Tubular Cells.

Authors:  Sun-hyo Lee; Jin-sun Kim; Kameswaran Ravichandran; Hyo-Wook Gil; Ho-yeon Song; Sae-yong Hong
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.